Status:
COMPLETED
Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
Lead Sponsor:
Emory University
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18-89 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if intense control of high glucose levels in patients treated with angioplasty for heart attack has anti-inflammatory and anti-thrombotic effects.
Detailed Description
Two out of three heart attack patients have high blood sugar. Half of these patients have diabetes and the other half have what is called pre-diabetes, meaning that they have higher blood sugar than n...
Eligibility Criteria
Inclusion
- Patients to be treated with percutaneous coronary intervention for myocardial infarction.
Exclusion
- MI \> 6 hrs duration Thrombolytic therapy (within last 2 days) Recent inflammatory/infectious illness (last 2 weeks) Pregnancy Renal insufficiency (Cr \> 2.0) Type I Diabetes Mellitus Initial BG \>110 but \<140 Enrollment in another research study
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00209144
Start Date
October 1 2004
End Date
December 1 2006
Last Update
June 16 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University Hospital
Atlanta, Georgia, United States, 30322
2
Emory Crawford Long Hospital
Atlanta, Georgia, United States, 30329